Share-Based Compensation (Tables)

6 Months Ended

Jun. 30, 2024

Restricted Shares

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Summary of Stock Compensation Expense

The following table summarizes restricted stock compensation expense for the six months ended June 30, 2024 and 2023:

	Six Months Ended June 30,
	2024		2023
Total share-based compensation - restricted stock	$	3,687	$	3,217
Income tax benefit		1,012		866
Unrecognized compensation expense		13,462		12,757
Weighted average remaining amortization period	2.1 years		2.3 years

Performance Share

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Summary of fair value of the total stock return performance-based awards granted

The fair value of the total stock return performance-based awards granted in 2024 and 2023 were calculated based on a Monte Carlo simulation, using the following assumptions:

	Performance Based Grants
	2024			2023
Risk-free interest rate		4.47	%		4.42	%
Expected term (years)	2.85 years			2.85 years
Expected stock price volatility	29.28% - 33.68%			38.11% - 39.80%
Weighted average grant date fair value	$	20.18		$	25.20

Omnibus Plan

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Summary of Changes in Restricted Shares

The following table discloses the changes in restricted shares for the six months ended June 30, 2024:

	Omnibus Plan
	Number of Shares			Weighted Average Grant Date Fair Value
Beginning balance, January 1, 2024		627,271		$	24.24
Granted		376,799			20.92
Incremental performance shares issued and vested		13,632
Vested		(234,308	)		22.57
Forfeited		(15,148	)		24.28
Ending balance outstanding at June 30, 2024		768,246		$	23.04

BYB Plan

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Summary of Activity in shares Subjected to Options and Weighted Average Exercise Prices

The following table discloses the activity in shares subject to options and the weighted average exercise prices, in actual dollars, for the six months ended June 30, 2024:

	BYB Plan
	Number of Shares			Weighted Average Exercise Price		Intrinsic Value		Weighted Average Remaining Contractual Term (in Years)
Beginning balance, January 1, 2024		768,564		$	11.31	$	9,413		1.5
Exercised		(231,294	)		11.18	$	2,782
Expired		—
Ending balance outstanding at June 30, 2024		537,270		$	11.37	$	6,647		0.9
Exercisable at June 30, 2024		537,270		$	11.37	$	6,647		0.9

FEB Plan

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Summary of Activity in shares Subjected to Options and Weighted Average Exercise Prices

The following table discloses the activity in shares subject to options under the FEB Plan and the weighted average exercise prices, in actual dollars, for the year ended June 30, 2024:

	FEB Plan
	Number of Shares			Weighted Average Exercise Price		Intrinsic Value		Weighted Average Remaining Contractual Term (in Years)
Beginning balance, January 1, 2024		103,135		$	11.95	$	1,197		1.9
Exercised		(3,000	)	$	11.65	$	37
Expired		—
Ending balance outstanding at June 30, 2024		100,135		$	11.96	$	1,179		1.4
Exercisable at June 30, 2024		100,135		$	11.96	$	1,179		1.4